ArticleHuman vaccines & immunotherapeutics2026
Integrating non-neonatal tetanus vaccination into an emergency department rabies PEP clinic: Real-world workload, documentation gaps, and VAERS-informed observation priorities.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Behavioural and service-context correlates of tetanus vaccination intention after trauma exposure in China: a cross-sectional BeSD study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Animal-bite and scratch visits to the emergency department (ED) often require time-sensitive decisions on rabies post-exposure prophylaxis (PEP) alongside tetanus prevention. In China, recent national standards and local implementation programs have framed non-neonatal tetanus prevention as an integrated medical-public health service model, yet integrated workflows and structured documentation remain uncommon in many tertiary hospitals. We reviewed patients presenting for their first recorded exposure to a dedicated ED rabies PEP clinic (8 Oct 2022-31 Oct 2025; n = 3,365) to describe real-world encounter characteristics and quantify implementation-relevant workload. Grade III exposures accounted for 73.6% of presentations, and 93.1% of patients presented on the same day. While grade III encounters form a practical priority subgroup for tetanus management, grade II/III encounters represented 99.4% of visits, indicating that tetanus immunization-history review and wound tetanus-risk documentation would need to be routine steps for nearly all PEP encounters. However, tetanus-related elements (immunization history, Td/Tdap/TT vaccination, tetanus immunoglobulin/antitoxin use) were not captured in structured registry fields, and Td/Tdap/TT vaccination is not routinely available in our ED clinic workflow, highlighting a quality improvement opportunity for standardized implementation. To provide external pharmacovigilance context in the absence of local coadministration safety data, we summarized adult VAERS reports listing both rabies vaccine and Td/Tdap/TT in 2022-2025 (n = 9; serious reports 0/9) and explored predefined disproportionality signals in 2006-2025. In sensitivity analyses, syncope and hypersensitivity showed increased reporting odds in reports listing both vaccines compared with rabies-only reports. These VAERS findings are presented as hypothesis-generating only: they identify potential event categories that may warrant awareness and documentation if multiple vaccines are administered during one encounter, but they do not confirm same-day administration, estimate incidence, or support causal inference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.